LFMD LIFEMD INC

LifeMD to Participate in Upcoming Investor and Industry Conferences During May

LifeMD to Participate in Upcoming Investor and Industry Conferences During May

NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor and industry conferences during the month of May:

  • BTIG Obesity Health Forum, May 8, 2024. Management will participate in a virtual panel titled Obesity Management with Coaching, Eating, and Lifestyle Management moderated by equity research analyst David Larsen.



  • Citizens JMP Securities Life Sciences Conference, May 13-14, 2024 at the New York Hilton Midtown. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.



  • Obesity+Health Conference hosted by Digital Health New York, May 14, 2024 at NYU Langone Health. LifeMD’s Chief Medical Officer Dr. Anthony Puopolo will speak about optimal obesity care on a panel with other thought leaders. To register for the conference, click .



  • RBC Capital Markets Global Healthcare Conference, May 14-15, 2024 at the InterContinental Barclay Hotel, New York. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.



  • Needham 19th Annual Technology, Media & Consumer Conference, May 14-16, 2024 at the Westin Grand Central Hotel, New York. Management will be holding one-on-one meetings with investors.



  • H.C. Wainwright 2nd Annual BioConnect Investor Conference at Nasdaq, May 20, 2024. Management will be holding one-on-one meetings with investors.



  • B. Riley Securities 24th Annual Institutional Investor Conference, May 22-23, 2024 at The Beverly Hilton in Beverly Hills. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.



  • Craig-Hallum 21st Annual Institutional Investor Conference, May 29, 2024 at The Depot Renaissance Minneapolis Hotel. Management will be holding one-on-one and small group meetings with investors.

About LifeMD, Inc.

LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit .

Investor Contact

Marc Benathen, Chief Financial Officer

Media Contact

Jessica Friedeman, Chief Marketing Officer



EN
23/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-...

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes NEW YORK and BOSTON, May 02, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: LFMD), a leading provider of virtual primary care services, and , a leader in digital health technology, announce a new strategic partnership designed to revolutionize weight management patient care by providing...

 PRESS RELEASE

LifeMD Appoints Dr. Calum MacRae to its Board of Directors

LifeMD Appoints Dr. Calum MacRae to its Board of Directors NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors. “We are delighted to welcome Dr. MacRae to the LifeMD Board of Directors. He brings deep experience in cardiology, internal medicine and clinical innovation, with a focus on disease management and the implementation of novel solutions to impr...

 PRESS RELEASE

LifeMD to Report First Quarter 2024 Financial Results on May 8

LifeMD to Report First Quarter 2024 Financial Results on May 8 NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on May 8, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Wednesday, May 8thTime:4:30 p.m. Eastern timeToll-Free Dial-In:1-888-886-7786International Dial-In:1-416-764-8658Conference ID:51137398Live & Archived Web...

 PRESS RELEASE

LifeMD to Participate in Upcoming Investor and Industry Conferences Du...

LifeMD to Participate in Upcoming Investor and Industry Conferences During May NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor and industry conferences during the month of May: BTIG Obesity Health Forum, May 8, 2024. Management will participate in a virtual panel titled Obesity Management with Coaching, Eating, and Lifestyle Management moderated by equity research analyst David Larsen.Citizens JMP Securities Life Sciences Conference, May 13-14...

 PRESS RELEASE

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on April 15, 2024 to holders of record at the close of business on April 5, 2024. About LifeMDLifeMD is a leading provider of virtual primary care. LifeMD ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch